BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6099768)

  • 1. Influence of intracerebroventricular (ICV) GTP-electrolyte infusion on ICV (D-ALA2, D-LEU5) enkephalin (DADL)-induced cardiovascular effects in rats.
    McDonald WJ; Notter M; Ganten D; Lang RE
    Clin Exp Hypertens A; 1984; 6(10-11):1837-41. PubMed ID: 6099768
    [No Abstract]   [Full Text] [Related]  

  • 2. A quantitative study of [3H]D-Ala2-D-Leu5-enkephalin binding to rat brain membranes. Evidence that oxymorphone is a noncompetitive inhibitor of the lower affinity delta-binding site.
    Rothman RB; Bowen WD; Herkenham M; Jacobson AE; Rice KC; Pert CB
    Mol Pharmacol; 1985 Mar; 27(3):399-409. PubMed ID: 2579319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morphine-like discriminative stimulus effects of opioid peptides: possible modulatory role of D-Ala2-D-Leu5-enkephalin (DADL) and dynorphin A (1-13).
    Ukai M; Holtzman SG
    Psychopharmacology (Berl); 1988; 94(1):32-7. PubMed ID: 2894701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular and respiratory effects of mu-, delta- and kappa-opiate agonists microinjected into the anterior hypothalamic brain area of awake rats.
    Pfeiffer A; Feuerstein G; Kopin IJ; Faden AI
    J Pharmacol Exp Ther; 1983 Jun; 225(3):735-41. PubMed ID: 6306217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma catecholamine and cardiovascular responses to morphine and D-ala2-d-leu5-enkephalin in conscious rats.
    Conway EL; Brown MJ; Dollery CT
    Arch Int Pharmacodyn Ther; 1983 Oct; 265(2):244-58. PubMed ID: 6360061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of an opioid-evoked vagal reflex in rats by naloxone, SMS 201-995 and ICI 154, 129.
    Kiang JG; Wei ET
    Regul Pept; 1983 Jul; 6(3):255-62. PubMed ID: 6137865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central effects of mu, delta, and kappa receptor agonists in hemorrhagic shock.
    Feuerstein G; Powell E; Faden AI
    Peptides; 1985; 6 Suppl 1():11-3. PubMed ID: 2995939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anterograde transport of opioid receptors in rat vagus nerves and dorsal roots of spinal nerves: pharmacology and sensitivity to sodium and guanine nucleotides.
    Zarbin MA; Wamsley JK; Kuhar MJ
    Exp Brain Res; 1990; 81(2):267-78. PubMed ID: 1697808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-localization of hypocretin-1 and leucine-enkephalin in hypothalamic neurons projecting to the nucleus of the solitary tract and their effect on arterial pressure.
    Ciriello J; Caverson MM; McMurray JC; Bruckschwaiger EB
    Neuroscience; 2013 Oct; 250():599-613. PubMed ID: 23912034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions of codeine-7,8-oxide (codeine-epoxide), as a new metabolite of codeine, with multiple opiate receptors.
    Konno F; Sato Y; Togashi K; Takayanagi I; Hirobe M
    Gen Pharmacol; 1985; 16(4):379-81. PubMed ID: 2995195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of mu, delta, kappa and epsilon opioid receptor agonists on heart rate and blood pressure of the pithed rat.
    Eimerl J; Feuerstein G
    Neuropeptides; 1986; 8(4):351-8. PubMed ID: 2881224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tolerance and cross tolerance to morphine after chronic spinal D-Ala2-D-Leu5-enkephalin infusion.
    Tseng LF
    Life Sci; 1982 Sep; 31(10):987-92. PubMed ID: 6752616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Partial cross tolerance to D-Ala2-D-Leu5-enkephalin after chronic spinal morphine infusion.
    Tseng LF
    Life Sci; 1983 May; 32(22):2545-50. PubMed ID: 6304439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [D-Ala2,Leu5,Cys6]enkephalin: short-term agonist effects and long-term antagonism at delta opioid receptors.
    Calcagnetti DJ; Fanselow MS; Helmstetter FJ; Bowen WD
    Peptides; 1989; 10(2):319-26. PubMed ID: 2547203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose- and strain-dependent effects of dermorphin and [D-Ala2-D-Leu5]enkephalin on passive avoidance behavior in mice.
    Castellano C; Pavone F
    Behav Neurosci; 1985 Dec; 99(6):1120-7. PubMed ID: 2886135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of tail-flick and shaking responses by intrathecal and intraventricular D-Ala2-D-Leu5-enkephalin and beta-endorphin in anesthetized rats.
    Tseng LF; Cheng SS; Fujimoto JM
    J Pharmacol Exp Ther; 1983 Jan; 224(1):51-4. PubMed ID: 6294283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of D-ala2, D-Leu5-enkephalin injections into the nucleus accumbens on the motility of rats.
    Havemann U; Winkler M; Kuschinsky K
    Life Sci; 1983; 33 Suppl 1():627-30. PubMed ID: 6363855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guanine nucleotide and cation regulation of mu, delta, and kappa opioid receptor binding: evidence for differential postnatal development in rat brain.
    Szücs M; Spain JW; Oetting GM; Moudy AM; Coscia CJ
    J Neurochem; 1987 Apr; 48(4):1165-70. PubMed ID: 3029328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential cardiovascular effects of mu, delta and kappa opiate agonists at discrete hypothalamic sites in the anesthetized rat.
    Feuerstein G; Faden AI
    Life Sci; 1982 Nov 15-22; 31(20-21):2197-200. PubMed ID: 6131355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective cardiorespiratory effects mediated by mu opioid receptors in the nucleus ambiguus.
    Hassen AH; Feuerstein G; Faden AI
    Neuropharmacology; 1984 Apr; 23(4):407-15. PubMed ID: 6328352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.